ScoreWhy is Hamlet BioPharma AB ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-179.42%
EBIT to Interest (avg)
-30.81
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
19.72
EV to EBIT
-12.76
EV to EBITDA
-15.74
EV to Capital Employed
27.61
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-216.29%
ROE (Latest)
-150.48%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
NET PROFIT(HY)
Higher at SEK -26.89 MM
RAW MATERIAL COST(Y)
Fallen by 0% (YoY
-11What is not working for the Company
INTEREST(9M)
At SEK 0.02 MM has Grown at 376.74%
OPERATING CASH FLOW(Y)
Lowest at SEK -39.66 MM
NET PROFIT(HY)
At SEK -26.89 MM has Grown at -25.38%
Here's what is working for Hamlet BioPharma AB
Net Profit
Higher at SEK -26.89 MM
than preceding 12 month period ended Mar 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (SEK MM)
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at SEK 2.64 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (SEK MM)
Here's what is not working for Hamlet BioPharma AB
Interest
At SEK 0.02 MM has Grown at 376.74%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SEK MM)
Operating Cash Flow
Lowest at SEK -39.66 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (SEK MM)
Net Profit
At SEK -26.89 MM has Grown at -25.38%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (SEK MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
